Mak, Lung-Yi
Liu, Sze-Hang
Yap, Desmond Yat-Hin
Seto, Wai-Kay
Wong, Danny Ka-Ho
Fung, James
Chan, Tak-Mao
Lai, Ching-Lung
Yuen, Man-Fung
Article History
Received: 8 February 2019
Accepted: 2 July 2019
First Online: 6 July 2019
Compliance with Ethical Standards
:
: WK Seto is an advisory board member of Gilead Sciences and Bristol-Myers Squibb and received speaker fees from Gilead Sciences, Bristol-Myers Squibb, and Novartis. J Fung received research funding from Novartis. CL Lai received speaker fees from Bristol-Myers Squibb, Novartis and Gilead Sciences, and is an advisory board member of Gilead Sciences. MF Yuen received speaker fees from GlaxoSmithKline, Bristol-Myers Squibb, Novartis, and Gilead Sciences; and received research funding and is an advisory board member of Bristol-Myers Squibb, Novartis, and Gilead Sciences. The remaining authors have no conflict of interest.